Italy Autoimmune Hemolytic Anemia Treatment Market Size & Outlook
Related Markets
Italy autoimmune hemolytic anemia treatment market highlights
- The Italy autoimmune hemolytic anemia treatment market generated a revenue of USD 22.6 million in 2023 and is expected to reach USD 34.8 million by 2030.
- The Italy market is expected to grow at a CAGR of 6.4% from 2024 to 2030.
- In terms of segment, warm autoimmune hemolytic anemia was the largest revenue generating type in 2023.
- Cold Autoimmune Hemolytic Anemia is the most lucrative type segment registering the fastest growth during the forecast period.
Autoimmune hemolytic anemia treatment market data book summary
| Market revenue in 2023 | USD 22.6 million |
| Market revenue in 2030 | USD 34.8 million |
| Growth rate | 6.4% (CAGR from 2024 to 2030) |
| Largest segment | Warm autoimmune hemolytic anemia |
| Fastest growing segment | Cold Autoimmune Hemolytic Anemia |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Warm Autoimmune Hemolytic Anemia, Cold Autoimmune Hemolytic Anemia |
| Key market players worldwide | Roche Holding AG ADR, Viatris Inc, Teva Pharmaceutical Industries Ltd, Sanofi SA, Lupin, Johnson & Johnson, Novartis AG ADR, Incyte Corp, Rigel Pharmaceuticals Inc, Vertex Pharmaceuticals Inc |
Other key industry trends
- In terms of revenue, Italy accounted for 3.0% of the global autoimmune hemolytic anemia treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany autoimmune hemolytic anemia treatment market is projected to lead the regional market in terms of revenue in 2030.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 29.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Autoimmune Hemolytic Anemia Treatment Market Scope
Autoimmune Hemolytic Anemia Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Rigel Pharmaceuticals Inc | View profile | 147 | 611 Gateway Boulevard, Suite 900, South San Francisco, CA, United States, 94080 | https://www.rigel.com |
| Vertex Pharmaceuticals Inc | View profile | 5400 | 50 Northern Avenue, Boston, MA, United States, 02210 | https://www.vrtx.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Incyte Corp | View profile | 2524 | 1801 Augustine Cut-Off, Wilmington, DE, United States, 19803 | https://www.incyte.com |
| Lupin | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | https://www.lupin.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Italy autoimmune hemolytic anemia treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to autoimmune hemolytic anemia treatment market will help companies and investors design strategic landscapes.
Warm autoimmune hemolytic anemia was the largest segment with a revenue share of 72.57% in 2023. Horizon Databook has segmented the Italy autoimmune hemolytic anemia treatment market based on warm autoimmune hemolytic anemia, cold autoimmune hemolytic anemia covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Italy autoimmune hemolytic anemia treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy autoimmune hemolytic anemia treatment market databook
-
Our clientele includes a mix of autoimmune hemolytic anemia treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy autoimmune hemolytic anemia treatment market , including forecasts for subscribers. This country databook contains high-level insights into Italy autoimmune hemolytic anemia treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy autoimmune hemolytic anemia treatment market size, by type, 2018-2030 (US$M)
Italy Autoimmune Hemolytic Anemia Treatment Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
